Up to $1.4B in Milestones
Molecular Partners Gets $62.5M as Allergan Repeats on Darpins
By Cormac Sheridan
Wednesday, August 22, 2012
Molecular Partners AG is banking $62.5 million up front and could receive up to $1.4 billion more in development, regulatory and commercial milestones in its second ophthalmology deal with Allergan Inc.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.